You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Claims for Patent: 10,973,811


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,973,811
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:16/563,454
Patent Claims: 1. A method of administering a local anesthetic prior to performing a diagnostic or surgical procedure on a renally impaired subject comprising: soaking one or more pledgets in up to about 4 mL of a ready-to-use composition comprising about 3.6% to about 4.4% cocaine hydrochloride, by weight, a preservative, an acidulant, and optionally, at least one coloring additive; contacting each pledget on a nasal mucous membrane of the subject up to about 20 minutes; and removing each pledget from contact with a mucous membrane.

2. The method of claim 1, wherein, the renally impaired subject has an estimated glomerular filtration rate (eGFR) in the range of about 15 mL/min./1.73 m.sup.2 to less than 60 mL/min./1.73 m.sup.2.

3. The method of claim 1, wherein, the renally impaired subject has an estimated glomerular filtration rate (eGFR) in the range of about 15 mL/min./1.73 m.sup.2 to less than about 29 mL/min./1.73 m.sup.2.

4. The method of claim 1, wherein the procedure comprises nasal endoscopy.

5. The method of claim 1, wherein the procedure comprises nasal laryngoscopy.

6. The method of claim 1, wherein the procedure comprises nasal debridement.

7. The method of claim 1, wherein the procedure comprises nasopharyngeal laryngoscopy.

8. The method of claim 1, wherein the procedure comprises laryngoscopy.

9. The method of claim 1, wherein the method achieves an absorptivity factor for cocaine in the subject in the range of 0.640 h.sup.-1 to 0.687 h.sup.-1.

10. The method of claim 1, wherein the method achieves an absorptivity factor for cocaine in the subject in the range of 0.483 h.sup.-1 to 0.789 h.sup.-1.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.